Department of Biostatistics, Gilead Sciences, Foster City, CA, USA.
School of Mathematics and Statistics, The University of Melbourne, Parkville, Victoria, Australia.
Pharm Stat. 2024 Jul-Aug;23(4):466-479. doi: 10.1002/pst.2355. Epub 2024 Jan 28.
As an alternative to the Frequentist p-value, the Bayes factor (or ratio of marginal likelihoods) has been regarded as one of the primary tools for Bayesian hypothesis testing. In recent years, several researchers have begun to re-analyze results from prominent medical journals, as well as from trials for FDA-approved drugs, to show that Bayes factors often give divergent conclusions from those of p-values. In this paper, we investigate the claim that Bayes factors are straightforward to interpret as directly quantifying the relative strength of evidence. In particular, we show that for nested hypotheses with consistent priors, the Bayes factor for the null over the alternative hypothesis is the posterior mean of the likelihood ratio. By re-analyzing 39 results previously published in the New England Journal of Medicine, we demonstrate how the posterior distribution of the likelihood ratio can be computed and visualized, providing useful information beyond the posterior mean alone.
作为频率派 p 值的替代方法,贝叶斯因子(或边缘似然比)已被视为贝叶斯假设检验的主要工具之一。近年来,一些研究人员开始重新分析来自著名医学期刊以及 FDA 批准药物试验的结果,以表明贝叶斯因子通常会得出与 p 值不同的结论。在本文中,我们研究了一种说法,即贝叶斯因子可以直接作为证据相对强度的直接量化指标,从而很容易进行解释。具体来说,我们表明对于具有一致先验的嵌套假设,零假设相对于备择假设的贝叶斯因子是似然比的后验均值。通过重新分析之前在《新英格兰医学杂志》上发表的 39 个结果,我们展示了如何计算和可视化似然比的后验分布,从而提供了超出后验均值的有用信息。